Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Non-HLA antibody responses following solid organ transplantation have become increasingly emphasised, with several large clinical series suggesting that such responses contribute to late graft failure. Many of the responses described recognise both recipient and donor moieties of the target antigen and thus represent auto-, rather than allo-immunity. Within this rapidly evolving field, many questions remain unanswered: what triggers the response; how innate and adaptive humoral autoimmunity integrate; and most pressingly, how autoimmunity contributes to graft damage and its relationship to other effector mechanisms of graft rejection. This review summarises recent clinical and experimental studies of humoral autoimmunity in transplant rejection, and considers some of the answers to these questions.

More information Original publication

DOI

10.1016/j.cellimm.2020.104131

Type

Journal article

Publication Date

2020-08-01T00:00:00+00:00

Volume

354

Keywords

Allograft vasculopathy, Autoimmunity, Chronic rejection, Germinal centre, Natural antibody, Adaptive Immunity, Animals, Autoantibodies, Autoantigens, Autoimmunity, Graft Rejection, Humans, Immunity, Humoral, Immunity, Innate, Organ Transplantation, Transplantation, Homologous